Conjunctival Advancement Procedure for Repairing Conjunctival Exposure of the PreserFlo MicroShunt.

Autor:	Tanito M; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Iida M; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Murakami K; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Ida C; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Otani H; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Takagi K; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Harano A; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Ichioka S; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN., Sugihara K; Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, JPN.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Oct 26; Vol. 16 (10), pp. e72409. Date of Electronic Publication: 2024 Oct 26 (Print Publication: 2024).
DOI:	10.7759/cureus.72409
Abstrakt:	A 59-year-old Japanese woman with primary open-angle glaucoma underwent PreserFlo MicroShunt (PFM) (Santen Pharmaceutical Co., Ltd., Osaka, Japan) implantation in her left eye. Six weeks postoperatively, a conjunctival exposure of the posterior end of the device was observed, accompanied by aqueous leakage. The patient had no identifiable risk factors for exposure, such as previous conjunctival incisional surgeries, significant blepharitis, or needling procedures. Conjunctival advancement surgery was performed to cover the exposed device. After the sufficient dissection of scar tissue surrounding the PFM and the reapproximation of the conjunctiva, the device was successfully covered. Postoperatively, the filtration bleb remained formed, and the intraocular pressure (IOP) was controlled. No recurrence of device exposure was observed after 18 months of follow-up. Although PFM device exposure is a rare complication, it requires prompt surgical intervention to prevent infection and maintain IOP control. Conjunctival advancement surgery is an effective treatment option that allows for the repair of the exposure while preserving the filtration function of the device. Competing Interests: Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Masaki Tanito declare(s) personal fees from Santen Pharmaceutical Co., Ltd. Masaki Tanito received honorarium and research donations from Santen Pharmaceutical Co., Ltd. Other authors have no conflicts of interest associated with this report. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Tanito et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu